US Edition
Tsingke Showcases at AACR 2025 - Advancing Global Cancer Research with Integrated Synthesis Solutions - PressReach
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Tsingke Showcases at AACR 2025 - Advancing Global Cancer Research with Integrated Synthesis Solutions - PressReach
BEIJING, May 15, 2025 /PRNewswire/ — Tsingke Biotech proudly participated in the AACR Annual Meeting 2025, held this April in Chicago, USA. As one of the world’s premier events in oncology research, AACR gathered global leaders from academia and industry to explore the future of cancer diagnostics and therapeutics. At Booth #3255, Tsingke presented its comprehensive synthesis and expression service portfolio, offering essential support from earl…
AACR CEO Margaret Foti, PhD, MD (hc): Thank you for an outstanding AACR Annual Meeting 2025 - AACR Annual Meeting News
Margaret Foti, PhD, MD (hc) The AACR Annual Meeting is the touchstone of the cancer research community, each year bringing together thousands of cancer scientists, clinicians, other health care professionals, survivors, and patient advocates from around the world to discuss the latest research advances, connect with one another, and forge new collaborations. It was an immense privilege to witness so many scientific breakthroughs being shared at …
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
